Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 22, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 114,793 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on December 21, 2005, and the Company was advised of it on December 22, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The transaction is noted as being in accordance with Disclosure Rule 3.1.4R(1)(b). The GSK Trust is identified as a discretionary trust where all current and former employees are potential beneficiaries.
Key Facts for Investor Verification
- Transaction Date: December 21, 2005.
- Shares Transferred: 114,793 Ordinary Shares.
- Source: GlaxoSmithKline Employee Trust (GSK Trust).
- Recipient: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Directors with Interest: Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop hold interests in the GSK Trust similar to other employees.